15 Einträge gefunden

1. The economics of basiliximab (Simulect) in preventing acute rejection in renal transplantation.

   1. Chilcott, James B
   2. Holmes, Michael W
   3. Walters, Stephen
   4. Akehurst, Ronald L
   5. Nashan, Björn

   2002 - Forschungsinformationssystem des UKE
2. Kidney transplant in children weighing less than 15 kg: donor selection and technical considerations.

   1. Neipp, Michael
   2. Offner, Gisela
   3. Lück, Rainer
   4. Latta, Kay
   5. Strehlau, Jürgen
   6. Schlitt, Hans J
   7. Ehrich, Jochen H H

   2002 - Forschungsinformationssystem des UKE
3. Expansion of the donor pool in liver transplantation: the Hannover experience 1996-2002.

   1. Nashan, Björn
   2. Lück, Rainer
   3. Becker, Thomas
   4. Grannas, Gerrit
   5. Strassburg, C
   6. Schneider, A
   7. Melter, M

   2002 - Forschungsinformationssystem des UKE
4. First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients.

   1. Klemens, Budde
   2. Schmouder, Robert L
   3. Brunkhorst, Reinhard
   4. Nashan, Björn
   5. Lücker, Peter W
   6. Mayer, Thomas
   7. Choudhury, Somesh

   2002 - Forschungsinformationssystem des UKE
5. Single centre experience with basiliximab in paediatric renal transplantation.

   1. Pape, Lars
   2. Strehlau, Juergen
   3. Henne, Thomas
   4. Latta, Kay
   5. Nashan, Björn
   6. Ehrich, Jochen H H
   7. Klempnauer, Juergen

   2002 - Forschungsinformationssystem des UKE
6. Hepatic reticuloendothelial function during parenteral nutrition including an MCT/LCT or LCT emulsion after liver transplantation - a double-blind study.

   1. Kuse, Ernst R
   2. Kotzerke, Joerg
   3. Müller, Silke
   4. Nashan, Björn
   5. Lück, Rainer
   6. Jaeger, Karsten

   2002 - Forschungsinformationssystem des UKE
7. Liver transplantation for liver cirrhosis in cystic fibrosis.

   1. Pfister, E
   2. Strassburg, A
   3. Nashan, Björn
   4. Becker, T
   5. Ballmann, M
   6. Arning, A
   7. Ehrich, J

   2002 - Forschungsinformationssystem des UKE
8. Long-term safety, tolerability and efficacy of daclizumab (Zenapax) in a two-dose regimen in liver transplant recipients.

   1. Niemeyer, Gerit
   2. Koch, Martina
   3. Light, Susan
   4. Kuse, Ernst R
   5. Nashan, Björn

   2002 - Forschungsinformationssystem des UKE
9. Successful outcome of acute graft-versus-host disease in a liver allograft recipient by withdrawal of immunosuppression.

   1. Lehner, F
   2. Becker, T
   3. Sybrecht, L
   4. Lück, R
   5. Schwinzer, R
   6. Slateva, K
   7. Blasczyk, R

   2002 - Forschungsinformationssystem des UKE
10. Review of the proliferation inhibitor everolimus.

    1. Nashan, Björn

    2002 - Forschungsinformationssystem des UKE
11. Pharmacokinetics, pharmacodynamics, and immunodynamics of daclizumab in a two-dose regimen in liver transplantation.

    1. Koch, Martina
    2. Niemeyer, Gerit
    3. Patel, Indravadan
    4. Light, Susan
    5. Nashan, Björn

    2002 - Forschungsinformationssystem des UKE
12. Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial.

    1. Neuhaus, Peter
    2. Clavien, Pierre-Alain
    3. Kittur, Dilip
    4. Salizzoni, Mauro
    5. Rimola, Antoni
    6. Abeywickrama, Kamal
    7. Ortmann, Elke

    2002 - Forschungsinformationssystem des UKE
13. Early clinical experience with a novel rapamycin derivative.

    1. Nashan, Björn

    2002 - Forschungsinformationssystem des UKE
14. Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors.

    1. Rosenau, Jens
    2. Bahr, Matthias J
    3. von Wasielewski, Reinhard
    4. Mengel, Michael
    5. Schmidt, Hartmut H J
    6. Nashan, Björn
    7. Lang, Hauke

    2002 - Forschungsinformationssystem des UKE
15. Basiliximab reduces acute liver allograft rejection in pediatric patients.

    1. Strassburg, A
    2. Pfister, E D
    3. Arning, A
    4. Nashan, Björn
    5. Ehrich, J H H
    6. Melter, M

    2002 - Forschungsinformationssystem des UKE